845 related articles for article (PubMed ID: 27288727)
1. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.
Yu-Wai-Man P; Griffiths PG; Chinnery PF
Prog Retin Eye Res; 2011 Mar; 30(2):81-114. PubMed ID: 21112411
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction as a cause of optic neuropathies.
Carelli V; Ross-Cisneros FN; Sadun AA
Prog Retin Eye Res; 2004 Jan; 23(1):53-89. PubMed ID: 14766317
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial optic neuropathies: how two genomes may kill the same cell type?
Carelli V; La Morgia C; Iommarini L; Carroccia R; Mattiazzi M; Sangiorgi S; Farne' S; Maresca A; Foscarini B; Lanzi L; Amadori M; Bellan M; Valentino ML
Biosci Rep; 2007 Jun; 27(1-3):173-84. PubMed ID: 17479363
[TBL] [Abstract][Full Text] [Related]
5. A Review of Mitochondrial Optic Neuropathies: From Inherited to Acquired Forms.
Pilz YL; Bass SJ; Sherman J
J Optom; 2017; 10(4):205-214. PubMed ID: 28040497
[TBL] [Abstract][Full Text] [Related]
6. [Vulnerability of retinal ganglion cells to mitochondrial defects].
Solano Palacios A
Arch Soc Esp Oftalmol; 2012 Mar; 87(3):69-71. PubMed ID: 22423654
[No Abstract] [Full Text] [Related]
7. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
Chun BY; Rizzo JF
Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.
Fu L; Kwok SS; Chan YK; Ming Lai JS; Pan W; Nie L; Shih KC
Biomed Res Int; 2019; 2019():8397521. PubMed ID: 31828134
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial optic neuropathies.
Carelli V; La Morgia C; Yu-Wai-Man P
Handb Clin Neurol; 2023; 194():23-42. PubMed ID: 36813316
[TBL] [Abstract][Full Text] [Related]
10. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Approaches to Inherited Optic Neuropathies.
Yu-Wai-Man P
Semin Neurol; 2015 Oct; 35(5):578-86. PubMed ID: 26444403
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies.
Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA
Exp Eye Res; 2011 Aug; 93(2):204-12. PubMed ID: 20691180
[TBL] [Abstract][Full Text] [Related]
13. Hereditary optic neuropathies share a common mitochondrial coupling defect.
Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
[TBL] [Abstract][Full Text] [Related]
14. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies.
La Morgia C; Ross-Cisneros FN; Sadun AA; Hannibal J; Munarini A; Mantovani V; Barboni P; Cantalupo G; Tozer KR; Sancisi E; Salomao SR; Moraes MN; Moraes-Filho MN; Heegaard S; Milea D; Kjer P; Montagna P; Carelli V
Brain; 2010 Aug; 133(Pt 8):2426-38. PubMed ID: 20659957
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options.
Carelli V; La Morgia C; Sadun AA
Curr Opin Neurol; 2013 Feb; 26(1):52-8. PubMed ID: 23302804
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for inherited optic neuropathies: past, present and future.
Yu-Wai-Man P; Votruba M; Moore AT; Chinnery PF
Eye (Lond); 2014 May; 28(5):521-37. PubMed ID: 24603424
[TBL] [Abstract][Full Text] [Related]
17. Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy.
Ratican SE; Osborne A; Martin KR
Neural Plast; 2018; 2018():7108948. PubMed ID: 29853847
[TBL] [Abstract][Full Text] [Related]
18. Optic neuropathies: the tip of the neurodegeneration iceberg.
Carelli V; La Morgia C; Ross-Cisneros FN; Sadun AA
Hum Mol Genet; 2017 Oct; 26(R2):R139-R150. PubMed ID: 28977448
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Membrane Dynamics and Inherited Optic Neuropathies.
Bagli E; Zikou AK; Agnantis N; Kitsos G
In Vivo; 2017; 31(4):511-525. PubMed ID: 28652416
[TBL] [Abstract][Full Text] [Related]
20. OPA1-associated disorders: phenotypes and pathophysiology.
Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
